Clinical Trials Logo

Cesarean Section clinical trials

View clinical trials related to Cesarean Section.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT05696678 Withdrawn - Postoperative Pain Clinical Trials

Improving ObsQoR-11 With Continuous Wound Infusion Versus Intrathecal Morphine After Elective Cesarean Delivery

CIVIMEC
Start date: February 2023
Phase: N/A
Study type: Interventional

The purpose of this prospective randomized double-blinded and controlled study is to evaluate the quality of recovery after elective cesarean delivery using the Obstetric Quality-of-Recovery-11 (ObsQoR-11) score at 24 hours between patients receiving intrathecal morphine (ITM group) compared to patients receiving a ropivacaine continuous wound infusion (CWI group).

NCT ID: NCT04232306 Withdrawn - Postoperative Pain Clinical Trials

Liposomal Bupivacaine + Bupivacaine vs. Bupivacaine Alone on Opioid Use After Elective c/Section

Start date: March 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effectiveness of local wound infiltration of EXPAREL® (liposomal bupivacaine) with bupivacaine HCl compared to active control with bupivacaine HCl alone following elective primary or repeat cesarean delivery with spinal anesthesia.

NCT ID: NCT03359798 Withdrawn - Opioid Use Clinical Trials

RCT of Counseling Intervention on Post-op Opiate Use

Start date: December 1, 2017
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial to investigate the effect of a simple counseling intervention on post-operative narcotic requirements, with the hypothesis that women receiving this intervention will use fewer narcotics for pain management following cesarean section.

NCT ID: NCT03335293 Withdrawn - Pregnancy Clinical Trials

RCT of Epinephrine (None, 100mcg, and 200mcg) in a Hyperbaric Bupivacaine, Fentanyl and Morphine Spinal in C-sections.

Start date: October 2019
Phase: Phase 4
Study type: Interventional

This is a prospective, randomized, double blind study of 75 patients (n=25 for each group) in which epinephrine (100mcg or 200mcg) or normal saline vehicle is added to intrathecal hyperbaric bupivacaine (0.75% bupivacaine hydrochloride in 8.25% dextrose), fentanyl, and morphine to prolong the duration of the spinal anesthetic in scheduled cesarean deliveries. The primary outcome of duration will be the time to T10 level sensory regression as well as motor level regression that will be graded via the modified Bromage scale. Repeat cesarean sections, in particular, are associated with increased operative time and thus often performed with a spinal-epidural (CSE) technique. The epidural component is, however, untested and may not provide adequate anesthesia, thus the higher risk of conversion to a general anesthesia. Epinephrine is routinely used to prolong spinal anesthesia. If effective for the duration of a repeat cesarean section it would obviate the additional time and risks of performing the epidural and still avoid sufficient duration to avoid conversion to a general anesthetic.

NCT ID: NCT03267628 Withdrawn - Pain, Acute Clinical Trials

Comparison of Intrathecal Morphine With the Quadratus Lumborum Type 2 Block for Post-operative Analgesia Following Elective Caesarean Section (QLBvITM Study)

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The investigators are comparing post operative analgesia provided for caesarean section patients, with the quadratus lumborum type 2 block and intrathecal morphine.

NCT ID: NCT03041220 Withdrawn - Cesarean Section Clinical Trials

Best Incision Site for Obese Patients - Low Versus High Transverse

Start date: December 2016
Phase:
Study type: Observational

Retrospective chart review using both out patient and inpatient records of obese patients (BMI of 30 or greater) who have had a cesarean section since the year 2009. We will evaluate the patient's BMI, their skin incision type at time of c-section, their co-morbidities, number of previous c-sections and post partum follow up for wound infection, wound separation and wound breakdown. We will also review operative notes to evaluate blood loss, length of surgery and complications during surgery. We will obtain maternal characteristics and information about the pregnancy.

NCT ID: NCT02323711 Withdrawn - Cesarean Section Clinical Trials

Dressing Versus Glue (2-Octyl Cyanoacrylate) for Coverage of the Skin Incision After Closure During Cesarean Delivery

Start date: January 2015
Phase: N/A
Study type: Interventional

This study is investigating the relative risks and benefits of using two common materials for coverage of the skin incision at cesarean delivery. We will perform the first prospective and the first randomized controlled trial examining the use of a standard postoperative dressing versus skin glue for coverage of the closed skin incision after cesarean delivery. The hypothesis is that using skin glue for coverage of the incision will be associated with decreased wound complications and increased patient satisfaction.

NCT ID: NCT01217580 Withdrawn - Cesarean Section Clinical Trials

Pain Relief Study of Ultrasound Guided Transverse Abdominis Plane(TAP)Block

TAP
Start date: October 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if injecting a local anesthetic, or numbing medication, above each hip will decrease the amount of narcotic pain medicine that is typically required by a patient after a cesarean delivery. Ultrasound pictures will be used to guide placement of this injection. Either ropivicaine (a type of numbing medication called a local anesthetic) or a placebo (saline) will be injected. For 24 hours, you will be given a button to press when you have pain. When the button is pressed, you will be given a small amount of pain medication called hydromorphone through your IV. You will also be given a pain medication called ketorolac through your IV every 8 hours for 24 hours after surgery.

NCT ID: NCT01211431 Withdrawn - Cesarean Section Clinical Trials

Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine

Start date: September 2010
Phase: Phase 4
Study type: Interventional

The goal is to compare the quality of post-cesarean analgesia, the side effects and the incidence of residual scar pain obtained with intrathecal morphine (reference treatment) or with a continuous intra-wound solution including both ropivacain and diclofenac (experimental treatment).

NCT ID: NCT00696462 Withdrawn - Cesarean Section Clinical Trials

The Effect of Forced Air Warming During Cesarean Section on Postoperative Infectious Morbidity

Start date: March 2007
Phase: N/A
Study type: Interventional

The purpose of this study will be to assess whether forced air warming decreases the rate of surgical site infections following cesarean section.